Source: Pharamceutical Technology

Flexion: Pacira to acquire Flexion Therapeutics to boost non-opioid pain portfolio

Pacira BioSciences has entered a definitive agreement to acquire biopharmaceutical firm Flexion Therapeutics to boost its non-opioid pain portfolio. The...Read More... The post Pacira to acquire Flexion Therapeutics to boost non-opioid pain portfolio appeared first on Pharmaceutical Technology.

Read full article »

Flexion's Competitors | Flexion's News | Flexion's Financials

Followers on Owler

120

Est. Annual Revenue

$100-500M

Est. Employees

250-500

CEO

Update CEO

CEO Approval Rating

- -/100

Flexion is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of musculoskeletal conditions.